Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Liver Diseases

  Free Subscription


Articles published in Int J Cancer

Retrieve available abstracts of 51 articles:
HTML format
Text format



Single Articles


    October 2017
  1. PAN R, Zhu M, Yu C, Lv J, et al
    Cancer incidence and mortality: A cohort study in China, 2008-2013.
    Int J Cancer. 2017;141:1315-1323.
    PubMed     Text format     Abstract available


    September 2017
  2. JIANG W, Shen Y, Ding Y, Ye C, et al
    A naive Bayes algorithm for tissue origin diagnosis (TOD-Bayes) of synchronous multifocal tumors in the hepatobiliary and pancreatic system.
    Int J Cancer. 2017 Sep 16. doi: 10.1002/ijc.31054.
    PubMed     Text format     Abstract available


  3. SONG IJ, Yang YM, Inokuchi-Shimizu S, Roh YS, et al
    The Contribution of Toll-Like Receptor Signaling to the Development of Liver Fibrosis and Cancer in Hepatocyte-Specific TAK1-Deleted Mice.
    Int J Cancer. 2017 Sep 5. doi: 10.1002/ijc.31029.
    PubMed     Text format     Abstract available


    August 2017
  4. LI S, Dai W, Mo W, Li J, et al
    By inhibiting PFKFB3, aspirin overcomes sorafenib resistance in hepatocellular carcinoma.
    Int J Cancer. 2017 Aug 31. doi: 10.1002/ijc.31022.
    PubMed     Text format     Abstract available


  5. DENG H, Eckel SP, Liu L, Lurmann FW, et al
    Particulate matter air pollution and liver cancer survival.
    Int J Cancer. 2017;141:744-749.
    PubMed     Text format     Abstract available


    July 2017
  6. YANG B, Petrick JL, Kelly SP, Graubard BI, et al
    Adiposity across the adult life course and incidence of primary liver cancer: The NIH-AARP cohort.
    Int J Cancer. 2017;141:271-278.
    PubMed     Text format     Abstract available


    June 2017
  7. LIN B, Zhu M, Wang W, Li W, et al
    Structural basis for alpha fetoprotein-mediated inhibition of caspase-3 activity in hepatocellular carcinoma cells.
    Int J Cancer. 2017 Jun 27. doi: 10.1002/ijc.30850.
    PubMed     Text format     Abstract available


  8. ZHANG Q, Yuan XF, Lu Y, Li ZZ, et al
    Surface expression of anti-CD3scfv stimulates locoregional immunotherapy against hepatocellular carcinoma depending on the E1A-engineered human umbilical cord mesenchymal stem cells.
    Int J Cancer. 2017 Jun 23. doi: 10.1002/ijc.30846.
    PubMed     Text format     Abstract available


  9. SHI H, Fang W, Liu M, Fu D, et al
    Complement component 1, q subcomponent binding protein (C1QBP) in lipid rafts mediates hepatic metastasis of pancreatic cancer by regulating IGF-1/IGF-1R signaling.
    Int J Cancer. 2017 Jun 12. doi: 10.1002/ijc.30831.
    PubMed     Text format     Abstract available


  10. WANG K, Nie X, Rong Z, Fan T, et al
    B lymphocytes repress hepatic tumorigenesis but not development in Hras12V transgenic mice.
    Int J Cancer. 2017 Jun 5. doi: 10.1002/ijc.30823.
    PubMed     Text format     Abstract available


  11. NDERITU P, Bosco C, Garmo H, Holmberg L, et al
    The association between individual metabolic syndrome components, primary liver cancer and cirrhosis: a study in the Swedish AMORIS cohort.
    Int J Cancer. 2017 Jun 2. doi: 10.1002/ijc.30818.
    PubMed     Text format     Abstract available


  12. MTEYREK A, Filipski E, Guettier C, Oklejewicz M, et al
    Critical cholangiocarcinogenesis control by cryptochrome clock genes.
    Int J Cancer. 2017;140:2473-2483.
    PubMed     Text format     Abstract available


    May 2017
  13. SHOJI H, Yoshio S, Mano Y, Doi H, et al
    Pro-angiogenic TIE-2-expressing monocytes/TEMs as a biomarker of the effect of sorafenib in patients with advanced hepatocellular carcinoma.
    Int J Cancer. 2017 May 27. doi: 10.1002/ijc.30804.
    PubMed     Text format     Abstract available


  14. CAI ZX, Chen G, Zeng YY, Dong XQ, et al
    Circulating tumor DNA profiling reveals clonal evolution and real-time disease progression in advanced hepatocellular carcinoma.
    Int J Cancer. 2017 May 22. doi: 10.1002/ijc.30798.
    PubMed     Text format     Abstract available


  15. CHU YJ, Yang HI, Wu HC, Liu J, et al
    Aflatoxin B1 exposure increases the risk of cirrhosis and hepatocellular carcinoma in chronic hepatitis B virus carriers.
    Int J Cancer. 2017 May 16. doi: 10.1002/ijc.30782.
    PubMed     Text format     Abstract available


  16. LEE TY, Wu JC, Yu SH, Lin JT, et al
    The occurrence of hepatocellular carcinoma in different risk stratifications of clinically non-cirrhotic non-alcoholic fatty liver disease.
    Int J Cancer. 2017 May 16. doi: 10.1002/ijc.30784.
    PubMed     Text format     Abstract available


    April 2017
  17. ZHANG R, Real CI, Liu C, Baba HA, et al
    Hepatic expression of oncogenes Bmi1 and Dkk1 is up-regulated in hepatitis B virus surface antigen-transgenic mice and can be induced by treatment with HBV particles or lipopolysaccharides in vitro.
    Int J Cancer. 2017 Apr 17. doi: 10.1002/ijc.30742.
    PubMed     Text format     Abstract available


  18. KE Y, Bao T, Zhou Q, Wang Y, et al
    Discs large homolog 5 decreases formation and function of invadopodia in human hepatocellular carcinoma via Girdin and Tks5: Dlg5 regulates HCC invadopodia.
    Int J Cancer. 2017 Apr 8. doi: 10.1002/ijc.30730.
    PubMed     Text format     Abstract available


    March 2017
  19. ZHU M, Li W, Lu Y, Dong X, et al
    HBx drives alpha fetoprotein expression to promote initiation of liver cancer stem cells through activating PI3K/AKT signal pathway.
    Int J Cancer. 2017;140:1346-1355.
    PubMed     Text format     Abstract available


  20. WANG W, Lie P, Guo M, He J, et al
    Risk of hepatotoxicity in cancer patients Treated with immune checkpoint inhibitors: a systematic review and meta-analysis of published data.
    Int J Cancer. 2017 Mar 6. doi: 10.1002/ijc.30678.
    PubMed     Text format     Abstract available


  21. MA X, Yang Y, Li HL, Zheng W, et al
    Dietary trace element intake and liver cancer risk: Results from two population-based cohorts in China.
    Int J Cancer. 2017;140:1050-1059.
    PubMed     Text format     Abstract available


    February 2017
  22. ZHANG D, Zhao L, Shen Q, Lv Q, et al
    Down-regulation of KIAA1199/CEMIP by miR-216a suppresses tumor invasion and metastasis in colorectal cancer.
    Int J Cancer. 2017 Feb 18. doi: 10.1002/ijc.30656.
    PubMed     Text format     Abstract available


  23. LI CH, Yen CH, Chen YF, Lee KJ, et al
    Characterization of the GNMT-HectH9-PREX2 Tripartite Relationship in the Pathogenesis of Hepatocellular Carcinoma.
    Int J Cancer. 2017 Feb 16. doi: 10.1002/ijc.30652.
    PubMed     Text format     Abstract available


  24. XU J, Lin H, Li G, Sun Y, et al
    Sorafenib with ASC-J9(R) synergistically suppresses the HCC progression via altering the pSTAT3-CCL2/Bcl2 signals.
    Int J Cancer. 2017;140:705-717.
    PubMed     Text format     Abstract available


    January 2017
  25. WANG W, Bai W, Wang E, Zhao Y, et al
    mRECIST response combined with sorafenib-related adverse events is superior to either criterion alone in predicting survival in HCC patients treated with TACE plus sorafenib.
    Int J Cancer. 2017;140:390-399.
    PubMed     Text format     Abstract available


    December 2016
  26. YANG X, Wu L, Lin J, Wang A, et al
    Distinct hepatitis B virus integration patterns in hepatocellular carcinoma and adjacent normal liver tissue.
    Int J Cancer. 2016 Dec 10. doi: 10.1002/ijc.30547.
    PubMed     Text format     Abstract available


  27. WU SM, Lin SL, Lee KY, Chuang HC, et al
    Hepatoma cell functions modulated by NEK2 are associated with liver cancer progression.
    Int J Cancer. 2016 Dec 7. doi: 10.1002/ijc.30559.
    PubMed     Text format     Abstract available


    November 2016
  28. MOHAMED NK, Hamad MA, Hafez MZ, Wooley KL, et al
    Nanomedicine in Management of Hepatocellular Carcinoma: Challenges and Opportunities.
    Int J Cancer. 2016 Nov 15. doi: 10.1002/ijc.30517.
    PubMed     Text format     Abstract available


  29. MANTHRAVADI S, Paleti S, Pandya P
    Impact of sustained viral response post curative therapy of hepatitis C-related hepatocellular carcinoma: A systematic review and meta-analysis.
    Int J Cancer. 2016 Nov 15. doi: 10.1002/ijc.30521.
    PubMed     Text format     Abstract available


  30. KIM G, Jang SY, Han E, Lee YH, et al
    Effect of statin on hepatocellular carcinoma in patients with type 2 diabetes: A nationwide nested case-control study.
    Int J Cancer. 2016 Nov 7. doi: 10.1002/ijc.30506.
    PubMed     Text format     Abstract available


    August 2016
  31. ZHAO Y, Li H, Bai W, Liu J, et al
    Early sorafenib-related adverse events predict therapy response of TACE plus sorafenib: A multicenter clinical study of 606 HCC patients.
    Int J Cancer. 2016;139:928-37.
    PubMed     Text format     Abstract available


  32. HASHIMOTO M, Kobayashi T, Tashiro H, Arihiro K, et al
    h-Prune is associated with poor prognosis and epithelial-mesenchymal transition in patients with colorectal liver metastases.
    Int J Cancer. 2016;139:812-23.
    PubMed     Text format     Abstract available


  33. KI KIM S, Ueda Y, Hatano E, Kakiuchi N, et al
    TERT promoter mutations and chromosome 8p loss are characteristic of nonalcoholic fatty liver disease-related hepatocellular carcinoma.
    Int J Cancer. 2016 Aug 11. doi: 10.1002/ijc.30379.
    PubMed     Text format     Abstract available


  34. KURAHARA H, Bohl C, Natsugoe S, Nishizono Y, et al
    Suppression of pancreatic cancer growth and metastasis by HMP19 identified through genome-wide shRNA screen.
    Int J Cancer. 2016;139:628-38.
    PubMed     Text format     Abstract available


    July 2016
  35. JARY M, Lecomte T, Bouche O, Kim S, et al
    Prognostic value of baseline seric Syndecan-1 in initially unresectable metastatic colorectal cancer patients: A simple biological score.
    Int J Cancer. 2016 Jul 29. doi: 10.1002/ijc.30367.
    PubMed     Text format     Abstract available


    June 2016
  36. XIE G, Wang X, Huang F, Zhao A, et al
    Dysregulated hepatic bile acids collaboratively promote liver carcinogenesis.
    Int J Cancer. 2016 Jun 7. doi: 10.1002/ijc.30219.
    PubMed     Text format     Abstract available


  37. SAHLMAN P, Nissinen M, Pukkala E, Farkkila M, et al
    Cancer incidence among alcoholic liver disease patients in Finland: A retrospective registry study during years 1996-2013.
    Int J Cancer. 2016;138:2616-21.
    PubMed     Text format     Abstract available


    May 2016
  38. RAMESH V, Ganesan K
    Integrative functional genomic delineation of the cascades of transcriptional changes involved in hepatocellular carcinoma progression.
    Int J Cancer. 2016 May 19. doi: 10.1002/ijc.30195.
    PubMed     Text format     Abstract available


    April 2016
  39. AIZAWA K, Liu C, Tang S, Veeramachaneni S, et al
    Tobacco carcinogen (NNK) induces both lung cancer and non-alcoholic steatohepatitis and hepatocellular carcinomas in ferrets which can be attenuated by lycopene supplementation.
    Int J Cancer. 2016 Apr 26. doi: 10.1002/ijc.30161.
    PubMed     Text format     Abstract available


  40. WANG C, Zhang Y, Guo K, Wang N, et al
    Heat shock proteins in hepatocellular carcinoma: Molecular mechanism and therapeutic potential.
    Int J Cancer. 2016;138:1824-34.
    PubMed     Text format     Abstract available


  41. EEFSEN RL, Engelholm L, Willemoe GL, Van den Eynden GG, et al
    Microvessel density and endothelial cell proliferation levels in colorectal liver metastases from patients given neo-adjuvant cytotoxic chemotherapy and bevacizumab.
    Int J Cancer. 2016;138:1777-84.
    PubMed     Text format     Abstract available


  42. JU HL, Han KH, Lee JD, Ro SW, et al
    Transgenic mouse models generated by hydrodynamic transfection for genetic studies of liver cancer and preclinical testing of anti-cancer therapy.
    Int J Cancer. 2016;138:1601-8.
    PubMed     Text format     Abstract available


    March 2016
  43. LOES IM, Immervoll H, Sorbye H, Angelsen JH, et al
    Impact of KRAS, BRAF, PIK3CA, TP53 status and intra-individual mutation heterogeneity on outcome after liver resection for colorectal cancer metastases.
    Int J Cancer. 2016 Mar 16. doi: 10.1002/ijc.30089.
    PubMed     Text format     Abstract available


  44. ZIMMERMANN E, Berentzen TL, Gamborg M, Sorensen TI, et al
    Sex-specific associations between birth weight and adult primary liver cancer in a large cohort of Danish children.
    Int J Cancer. 2016;138:1410-5.
    PubMed     Text format     Abstract available


    January 2016
  45. GHOSH A, Ghosh A, Datta S, Dasgupta D, et al
    Hepatic miR-126 is a Potential Plasma Biomarker for Detection of Hepatitis B Virus Infected Hepatocellular Carcinoma.
    Int J Cancer. 2016 Jan 12. doi: 10.1002/ijc.29999.
    PubMed     Text format     Abstract available


  46. SUN L, Hu S, Yu L, Guo C, et al
    Serum Haptoglobin as a novel molecular biomarker predicting colorectal cancer hepatic metastasis.
    Int J Cancer. 2016 Jan 12. doi: 10.1002/ijc.29993.
    PubMed     Text format     Abstract available


    December 2015
  47. MCGLYNN KA, Hagberg K, Chen J, Braunlin M, et al
    Menopausal hormone therapy use and risk of primary liver cancer in the Clinical Practice Research Datalink.
    Int J Cancer. 2015 Dec 13. doi: 10.1002/ijc.29960.
    PubMed     Text format     Abstract available


    September 2015
  48. TAKEUCHI S, Fukuda K, Arai S, Nanjo S, et al
    Organ-specific efficacy of HSP90 inhibitor in multiple-organ metastasis model of chemorefractory small cell lung cancer.
    Int J Cancer. 2015 Sep 17. doi: 10.1002/ijc.29858.
    PubMed     Text format     Abstract available


    August 2015
  49. WONG MC, Ching JY, Chan VC, Lam TY, et al
    Screening Strategies for Colorectal Cancer among Patients with Non-Alcoholic Fatty Liver Disease and Family History.
    Int J Cancer. 2015 Aug 20. doi: 10.1002/ijc.29809.
    PubMed     Text format     Abstract available


  50. CORREA D, Somoza RA, Lin P, Schiemann WP, et al
    Mesenchymal Stem Cells regulate Melanoma Cancer Cells extravasation to bone and liver at their perivascular niche.
    Int J Cancer. 2015 Aug 1. doi: 10.1002/ijc.29709.
    PubMed     Text format     Abstract available


    May 2015
  51. HLEYHEL M, Belot A, Bouvier AM, Tattevin P, et al
    Trends in survival after cancer diagnosis among HIV-Infected Individuals between 1992 and 2009. Results from the FHDH-ANRS CO4 Cohort.
    Int J Cancer. 2015 May 14. doi: 10.1002/ijc.29603.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Liver Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: